Al Jalila Foundation, a charitable arm of Dubai Health, has announced a donation of AED 50 million from the Al-Othman Endowment of the late Issa Abdullah Abdulaziz Al-Othman from Kuwait.

This funding will contribute to the construction and development of the Hamdan bin Rashid Cancer Hospital, which is poised to be Dubai's first fully integrated cancer hospital.

The donation agreement was signed by Dr. Amer Al Zarooni, Executive Director of Al Jalila Foundation, along with the endowment’s directors, Youssef, Nabil, and Abdullah Issa Abdullah Abdulaziz Al-Othman, at the foundation's headquarters in Dubai.

During their visit, the directors were presented with a detailed overview of the project and its goals, alongside a comprehensive explanation of the endowment itself.

They also toured the Al Jalila Foundation, examining various charitable initiatives and projects, including the biobank and the Mohammed Bin Rashid Center for Medical Research, as well as several projects supporting scientific and academic research.

Dr. Amer Al Zarooni expressed gratitude to the directors of the Al-Othman Endowment, highlighting that this generous donation will significantly impact many patients' lives.

He emphasized the importance of continuous support from philanthropists in sustaining charitable work and its positive effects on communities.

He noted that Dubai has successfully fostered a culture of sustainable giving and provided an attractive environment for strategic partnerships with a positive global impact.

The substantial support for the Hamdan bin Rashid Cancer Hospital is seen as a vital step towards providing comprehensive and high-quality healthcare for cancer patients.

This initiative embodies the spirit of giving and indicates a strong understanding of the foundation's efforts to improve patients' lives and offer hope to them and their families.

In recognition of this donation, the hospital’s intensive care unit will be named "Intensive Care Unit - Supported by the Issa Abdullah Al-Othman Endowment and the Taiba Abdulwahab Al-Othman Endowment - Kuwait."

Faisal Issa Abdullah Al-Othman, representing the endowment, underscored the significance of partnering with Al Jalila Foundation in this noble humanitarian project, named after the late Sheikh Hamdan bin Rashid Al Maktoum.

The project aims to provide comprehensive care for cancer patients.

He stated, "We believe that collaboration is the optimal path for achieving sustainable development, and our contribution to this essential project is a building block in a grand structure that expresses our gratitude and recognition towards the UAE, its leadership, and its people."

Faisal Al-Othman also explained that the contributions from the Al-Othman Endowment and the Taiba Abdulwahab Al-Othman Endowment reflect the values of generosity instilled in them by their late parents.

They dedicated their lives to community service and spread goodwill wherever they went.

Today, they are committed to following in their footsteps by supporting the healthcare sector and contributing to projects that make a positive difference in people's lives.

He hoped that this endowment would serve as a continuous charity that benefits cancer patients and alleviates their pain.

The Hamdan bin Rashid Cancer Hospital is set to be a comprehensive medical facility, equipped with state-of-the-art treatment technologies.

It will attract qualified medical personnel, including specialized doctors and trained nursing staff.

Additionally, the hospital aims to play a leading research and training role by exploring new treatment techniques for cancer and investing in the training and development of medical and nursing expertise to meet the hospital's needs and provide specialized treatment for cancer patients.

The hospital will feature seven floors covering an area of 56,000 square meters and will be the first hospital in Dubai to be built entirely with prefabricated modular units.

It will be equipped with cutting-edge medical and therapeutic technologies and is expected to provide treatment services to approximately 30,000 patients annually.